Breaking News Headlines Today

News from pharmafile.com

See all of pharmafile.com news coverage in one place. Discover how pharmafile.com’s media bias informs their coverage and compare with thousands of other news outlets.

Overall, we’ve indexed 178 stories from pharmafile.com over the past 3 months.

Ground News rates pharmafile.com’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

pharmafile.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about pharmafile.com

Where is pharmafile.com located?pharmafile.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans - Pharmafile

Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein research. Didier Dargent, who has served as chief executive officer (CEO), will assume the role of executive chairman. Michael Bencak, an experienced biotech executive, has been appointed as the new CEO of both Cube Biotech […] The post Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans ap…Read Article

Seaport Therapeutics doses first patient in trial of GlyphAllo for depression - Pharmafile

Seaport Therapeutics has dosed its first patient in its phase 2b BUOY-1 study of GlyphAllo (SPT-300), an oral prodrug of allopregnanolone, for the treatment of major depressive disorder (MDD), with or without anxious distress. GlyphAllo is designed using the company’s Glyph platform to overcome bioavailability limitations of allopregnanolone, a molecule known for its rapid antidepressant […] The post Seaport Therapeutics doses first patient in t…Read Article

PureTech Health appoints interim CEO Robert Lyne - Pharmafile

PureTech Health has announced the departure of chief executive officer (CEO) Bharatt Chowrira, who has stepped down from his role and as a member of the board of directors. Robert Lyne, who is currently chief portfolio officer, has been appointed interim CEO with immediate effect. Lyne, who joined PureTech in January 2024, brings significant experience […] The post PureTech Health appoints interim CEO Robert Lyne appeared first on Pharmafile.Read Article

OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile

OKYO Pharma has announced positive results from its phase 2 trial of urcosimod (formerly OK-101) in neuropathic corneal pain (NCP), an ocular condition characterised by chronic, nerve-related eye pain that currently lacks US Food and Drug Administration (FDA)-approved treatment. Conducted at Tufts Medical Center, Boston, US, the trial evaluated the safety and efficacy of urcosimod […] The post OKYO Pharma reports promising phase 2 results for ur…Boston, Massachusetts · Boston Read Article

Yourgene Health launches LightBench Discover for long-read sequencing labs - Pharmafile

Yourgene Health, part of the Novacyt group, has announced the launch of LightBench Discover, an integrated benchtop instrument designed to streamline workflows in genomic research labs using long-read sequencing. The three-in-one platform offers large fragment analytics, DNA size selection and fluorometric quantification. Developed in collaboration with PacBio, the LightBench Discover builds on the original LightBench, […] The post Yourgene Heal…Manchester, England · Manchester Read Article

Evestia Clinical and Atlantic Research Group merge to create global specialist CRO - Pharmafile

UK-based Evestia Clinical will merge with US-based Atlantic Research Group (ARG), forming a leading independent global contract research organisation (CRO) specialising in high-growth therapeutic areas. Backed by private equity firm Kester Capital, the move marks a significant step in Evestia’s strategy to grow globally through targeted acquisitions and service expansion. The merger more than doubles […] The post Evestia Clinical and Atlantic Re…United Kingdom · United Kingdom Read Article

Takara and Macherey-Nagel enter distribution agreement for global expansion - Pharmafile

Takara Bio Europe has entered into a distribution agreement with Macherey-Nagel (MN), an analytical and bioanalytical product provider, to expand its global development. Under this agreement, Takara Bio Europe will distribute MN’s bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the UK. Based in Düren, Germany, MN specialises in molecular […] The post Takara and Macherey-Nagel enter…Düren · Düren Read Article

LDC strengthens healthcare focus with appointment of Amit Thaper as investment director - Pharmafile

LDC, the private equity arm of Lloyds Banking Group, has strengthened its healthcare expertise with the appointment of Amit Thaper as investment director. Based in London, Thaper will focus on identifying new investment opportunities and supporting the growth of healthcare companies in the company’s portfolio. With nearly 15 years’ experience in private equity, Thaper brings […] The post LDC strengthens healthcare focus with appointment of Amit …London, England · London Read Article

Research Identifies Genetic Predictor of Weight Loss with GLP-1RAs

100% Center coverage: 1 sources

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic underpinnings of weight loss response has identified a gene, neurobeachin (NBEA), as a predictor of how individuals respond to GLP-1RAs, the class of medications behind popular treatments like liraglutide and semaglutide.Wegovy See the Story

News from pharmafile.com

News from pharmafile.com

Information about pharmafile.com

Media Bias Ratings

Factuality

Ownership

Top pharmafile.com News

Moderna’s Latest Approval Again Reveals FDA Rift over COVID Vaccines

Family History Shapes Psoriatic Disease Onset in PsA

Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans - Pharmafile

Seaport Therapeutics doses first patient in trial of GlyphAllo for depression - Pharmafile

PureTech Health appoints interim CEO Robert Lyne - Pharmafile

OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile

Yourgene Health launches LightBench Discover for long-read sequencing labs - Pharmafile

Evestia Clinical and Atlantic Research Group merge to create global specialist CRO - Pharmafile

Takara and Macherey-Nagel enter distribution agreement for global expansion - Pharmafile

LDC strengthens healthcare focus with appointment of Amit Thaper as investment director - Pharmafile

Research Identifies Genetic Predictor of Weight Loss with GLP-1RAs

Similar News Topics

Topics Most Covered by pharmafile.com

Sources Covering Similar Topics

Breaking News Topics Related to pharmafile.com

Information about pharmafile.com

Media Bias Ratings

Factuality

Ownership

Seaport Therapeutics doses first patient in trial of GlyphAllo for depression - Pharmafile

PureTech Health appoints interim CEO Robert Lyne - Pharmafile

OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile

Yourgene Health launches LightBench Discover for long-read sequencing labs - Pharmafile

Evestia Clinical and Atlantic Research Group merge to create global specialist CRO - Pharmafile

Takara and Macherey-Nagel enter distribution agreement for global expansion - Pharmafile

LDC strengthens healthcare focus with appointment of Amit Thaper as investment director - Pharmafile

Research Identifies Genetic Predictor of Weight Loss with GLP-1RAs